Effect of Pretransplant Infections on Clinical Outcomes in Live-Donor Liver Transplant Recipients

• Published in: Transplantation proceedings 2019-09, Vol.51 (7), p.2434-2438
• Main Authors: Cinar, Gule, Kalkan, İrem Akdemir, Azap, Alpay, Kirimker, Onur Elvan, Balci, Deniz, Keskin, Onur, Yuraydin, Cihan, Ormeci, Necati, Dokmeci, Abdulkadir
• Format: Article
• Language: English
• Subjects: Adult; Contraindications, Procedure; Diabetes Mellitus - epidemiology; Diabetes Mellitus - etiology; Diabetes Mellitus - mortality; End Stage Liver Disease - complications; End Stage Liver Disease - mortality; End Stage Liver Disease - surgery; Female; Hospitalization; Humans; Infections - etiology; Infections - mortality; Liver Transplantation - methods; Liver Transplantation - mortality; Living Donors; Male; Middle Aged; Postoperative Complications - etiology; Postoperative Complications - mortality; Preoperative Period; Reoperation - statistics & numerical data; Retrospective Studies; Risk Factors; Turkey; Young Adult
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2019.03.055

Owing to impaired immune function, surgical procedures, and multiple hospitalizations, patients with end-stage liver disease are at risk for numerous infectious complications while waiting for transplantation. Infection in transplant recipients remains the main cause of mortality and morbidity, despite advances in surgical techniques and the development of new repressive agents. The purpose of this study is to examine the infections that develop during the pretransplantion period in live donor liver transplant recipients and their effect on post-transplant clinical outcomes. The retrospective analysis of adult live donor liver transplant recipients in the last 4 years was conducted at Ankara University Hospital, a 1900-bed tertiary-care university hospital, in Ankara, Turkey. Demographic characteristics, preoperative infections, and clinical outcomes were analyzed. Patients were divided into 2 groups according to whether they had developed an infection before transplantation. The diagnoses were based on clinical, laboratory, and microbiological findings. Statistical analyses were performed using Stata version 9.0 (StataCorp, College Station, Tex., United States), and P < .05 were considered statistically significant. In univariate analyses, having diabetes mellitus or a pretransplant infection, the number of pretransplant infection attacks, the need for a reoperation, and developing a post-transplant infection were the statistically significant factors associated with 1-year mortality (P < .001, χ2 test). In multivariate analyses, diabetes mellitus (Odds ratio [OR] = 7.44, 95% confidence interval [CI], .03–45.79; P = .013), reoperation (OR = .33, 95% CI, .25–2.20; P < .001), having a pretransplantation infection (OR = 12.47, 95% CI, .011–87.67; P = .013), and the number of pretransplantation infection attacks (OR = .028, 95% CI, .013–.47; P < .001) were found to be statistically significant risk factors for 1-year mortality. Our study showed the effect of pretransplantation infections on post-transplant morbidity but not on rejection or mortality. According to the situation of patients, manageable pretransplantation infection is not an absolute contraindication for liver transplantation. Awareness of the increased risk for post-transplant infections and fast-acting antimicrobial coverage are the most important facts for patient survival.